These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7595170)

  • 1. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.
    Mulligan LM; Marsh DJ; Robinson BG; Schuffenecker I; Zedenius J; Lips CJ; Gagel RF; Takai SI; Noll WW; Fink M
    J Intern Med; 1995 Oct; 238(4):343-6. PubMed ID: 7595170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RET gene and its implications for cancer.
    Goodfellow PJ; Wells SA
    J Natl Cancer Inst; 1995 Oct; 87(20):1515-23. PubMed ID: 7563185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.
    Landsvater RM; Jansen RP; Hofstra RM; Buys CH; Lips CJ; Ploos van Amstel HK
    Hum Genet; 1996 Jan; 97(1):11-4. PubMed ID: 8557249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple endocrine neoplasia type 2A, type 2B and familial medullary thyroid carcinoma syndrome].
    Obara T; Yamashita T; Kanbe M; Ito Y; Egawa S; Yamaguchi K
    Nihon Rinsho; 1995 Nov; 53(11):2708-15. PubMed ID: 8538031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.
    Mulligan LM; Eng C; Attié T; Lyonnet S; Marsh DJ; Hyland VJ; Robinson BG; Frilling A; Verellen-Dumoulin C; Safar A
    Hum Mol Genet; 1994 Dec; 3(12):2163-7. PubMed ID: 7881414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia].
    Pomares Gómez FJ; Bernabé Espinosa MJ; Matías-Guiu Guía X; Rodríguez González JM; Soriano Palao J; Sola Pérez J; Carbonell Meseguer P; Parrilla Paricio P; Tébar Massó FJ
    Med Clin (Barc); 1999 May; 112(17):646-50. PubMed ID: 10374185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RET proto-oncogene and cancer.
    Donis-Keller H
    J Intern Med; 1995 Oct; 238(4):319-25. PubMed ID: 7595167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neural crest and multiple endocrinopathies].
    Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M
    C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
    Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
    Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.
    Frank-Raue K; Höppner W; Frilling A; Kotzerke J; Dralle H; Haase R; Mann K; Seif F; Kirchner R; Rendl J; Deckart HF; Ritter MM; Hampel R; Klempa J; Scholz GH; Raue F
    J Clin Endocrinol Metab; 1996 May; 81(5):1780-3. PubMed ID: 8626834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
    Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET mutations in exons 13 and 14 of FMTC patients.
    Bolino A; Schuffenecker I; Luo Y; Seri M; Silengo M; Tocco T; Chabrier G; Houdent C; Murat A; Schlumberger M
    Oncogene; 1995 Jun; 10(12):2415-9. PubMed ID: 7784092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma.
    Jhiang SM; Fithian L; Weghorst CM; Clark OH; Falko JM; O'Dorisio TM; Mazzaferri EL
    Thyroid; 1996 Apr; 6(2):115-21. PubMed ID: 8733882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.